• FDA Orphan Designation Moves Vybion’s Huntington’s Therapy Closer To Clinical Trial
  • Young People Caring for Huntington’s Disease Parent Worry ‘This Could Be Me’
  • Compound in Raspberries May Help Protect Against Huntington’s, Other Neurodegenerative Diseases, Study Says
  • Impaired Energy Metabolism Linked to Age of Onset in Huntington’s Patients, Study Shows
  • Juvenile Huntington’s More Aggressive, Leads to Early Symptoms, Study Reports
  • #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
  • DNA-based Therapy Reduces Anxious Behavior in Huntington’s Mouse Model, Study Shows
  • Gene Therapy VY-HTT01 Can Protect Brain Cells from Damage Caused by HTT Faulty Gene, Results Show
  • Advanced Huntington’s Patients Have Marked Difficulties in Driving, Study Shows
  • Neurological Dysfunction Detectable Before Huntington’s Diagnosis, Study Finds
  • New Blood Test May Track Early Changes in Huntington’s Disease, Study Finds
  • Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments